A comparative study on idiopathic pulmonary fibrosis and secondary diffuse parenchymal lung disease.

Abstract

symptoms and signs were noted more frequently with IPF, subjective improvement to treatment was noted in 63% and the best response was noted among patients diagnosed to have sarcoidosis. A prospective trial is needed to study the long term prognosis and therapeutic response among Indian patients.